Armis Biopharma Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 1

Armis Biopharma General Information

Description

Developer of non-systemic antimicrobial products intended to protect against resistant pathogens and chemical/biological warfare agents. The company's platform is a proprietary peracid/hydrogen peroxide-based non-systemic antimicrobial agent and has been independently verified to eliminate a wide range of bacterial, viral, fungal, and toxic agent threats, enabling organizations to serve a variety of markets, including healthcare, defense, and industry.

Contact Information

Formerly Known As
Chata Biosystems, CHD Bioscience
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2401 Research Boulevard
  • Suite 205
  • Fort Collins, CO 80562
  • United States
+1 (800)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • 2401 Research Boulevard
  • Suite 205
  • Fort Collins, CO 80562
  • United States
+1 (800)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Armis Biopharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Secondary Transaction - Private Completed Generating Revenue
8. Later Stage VC 10-Jul-2025 Completed Generating Revenue
7. Later Stage VC 15-Sep-2022 Completed Generating Revenue
6. Grant 15-Aug-2022 Completed Generating Revenue
5. Grant 09-Nov-2020 Completed Pre-Clinical Trials
4. Seed Round 24-Sep-2018 Completed Pre-Clinical Trials
3. Seed Round 17-Nov-2017 Completed Pre-Clinical Trials
2. Seed Round 01-Jan-2017 $5.5M $8.7M Completed Pre-Clinical Trials
1. Seed Round 16-Apr-2014 $3.2M $3.2M Completed Pre-Clinical Trials
To view Armis Biopharma’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Armis Biopharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of non-systemic antimicrobial products intended to protect against resistant pathogens and chemical/biological
Drug Discovery
Fort Collins, CO
10 As of 2022

Warminster, PA
 

Saint Paul, MN
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Armis Biopharma Competitors (3)

One of Armis Biopharma’s 3 competitors is Arbutus Biopharma, a Corporation company based in Warminster, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Arbutus Biopharma Corporation Warminster, PA
Ecolab Corporation Saint Paul, MN
GlaxoSmithKline (Consumer Healthcare Business) Corporate Backed or Acquired Brentford, United Kingdom
You’re viewing 3 of 3 competitors. Get the full list »

Armis Biopharma Patents

Armis Biopharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026213140-A1 Container for neutralizing substance Pending 31-Mar-2025
CA-3223608-A1 Sprayer head having integrated secondary internal liquid reservoir Pending 16-Aug-2021
EP-4387771-A1 Sprayer head having integrated secondary internal liquid reservoir Inactive 16-Aug-2021
US-20230415182-A1 Sprayer head having integrated secondary internal liquid reservoir Inactive 16-Aug-2021
US-20240173732-A1 Sprayer head having integrated secondary internal liquid reservoir Inactive 16-Aug-2021 B05B11/1011
To view Armis Biopharma’s complete patent history, request access »

Armis Biopharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Armis Biopharma Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institutes of Neurological Disorders and Stroke Government
To view Armis Biopharma’s complete investors history, request access »

Armis Biopharma FAQs

  • When was Armis Biopharma founded?

    Armis Biopharma was founded in 1997.

  • Where is Armis Biopharma headquartered?

    Armis Biopharma is headquartered in Fort Collins, CO.

  • What is the size of Armis Biopharma?

    Armis Biopharma has 10 total employees.

  • What industry is Armis Biopharma in?

    Armis Biopharma’s primary industry is Drug Discovery.

  • Is Armis Biopharma a private or public company?

    Armis Biopharma is a Private company.

  • What is Armis Biopharma’s current revenue?

    The current revenue for Armis Biopharma is .

  • How much funding has Armis Biopharma raised over time?

    Armis Biopharma has raised $28.9M.

  • Who are Armis Biopharma’s investors?

    National Institutes of Neurological Disorders and Stroke has invested in Armis Biopharma.

  • Who are Armis Biopharma’s competitors?

    Arbutus Biopharma, Ecolab, and GlaxoSmithKline (Consumer Healthcare Business) are competitors of Armis Biopharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process